Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Scinai Immunotherapeutics Ltd. - American Depositary Shares (NQ:SCNI)

1.530 +0.020 (+1.32%)
Streaming Delayed Price Updated: 10:44 AM EDT, Aug 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Scinai Immunotherapeutics Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Closes on $1.33M Registered Direct Offering
Via Investor Brand Network
Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Study Shows Climate Change Impacts Infectious Disease Risks
Via Investor Brand Network
Topics Climate Change
Why Food Allergy Prevalence Is Growing
Via Investor Brand Network
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results. 
Via Benzinga
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces $1.33M Registered Direct
Via Investor Brand Network
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 169 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports on Plaque Psoriasis Treatment Study
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) NanoAbs for Psoriasis Treatment May Offer Significant Advantages Over Apogee
Via Investor Brand Network
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.